Rice Hall James & Associates’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-351,837
| Closed | -$9.58M | – | 277 |
|
|
2019
Q4 | $9.58M | Sell |
351,837
-485,811
| -58% | -$13.2M | 0.32% | 107 |
|
|
2019
Q3 | $24M | Sell |
837,648
-15,731
| -2% | -$450K | 0.86% | 34 |
|
|
2019
Q2 | $23.7M | Sell |
853,379
-51,534
| -6% | -$1.43M | 0.79% | 35 |
|
|
2019
Q1 | $30M | Buy |
904,913
+104,360
| +13% | +$3.46M | 0.97% | 30 |
|
|
2018
Q4 | $23.3M | Buy |
+800,553
| New | +$23.3M | 0.85% | 33 |
|
|
2016
Q3 | – | Sell |
-526,184
| Closed | -$16.1M | – | 298 |
|
|
2016
Q2 | $16.1M | Buy |
+526,184
| New | +$16.1M | 0.93% | 41 |
|
|
2014
Q1 | – | Sell |
-62,526
| Closed | -$1.31M | – | 312 |
|
|
2013
Q4 | $1.31M | Buy |
62,526
+39,592
| +173% | +$831K | 0.09% | 206 |
|
|
2013
Q3 | $539K | Sell |
22,934
-5,655
| -20% | -$133K | 0.05% | 220 |
|
|
2013
Q2 | $768K | Buy |
+28,589
| New | +$768K | 0.08% | 197 |
|